Lymphokine-activated killer lymphocytes: evidence for regulation of induction and function by multiple cytokines

Affiliations

Review

L B Owen-Schaub et al. Immunol Ser. 1989.

. 1989:48:19-35.

No abstract available

Similar articles

Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
Harthun NL, Weaver AM, Brinckerhoff LH, Deacon DH, Gonias SL, Slingluff CL Jr. Harthun NL, et al. J Immunother. 1998 Mar;21(2):85-94. J Immunother. 1998. PMID: 9551359
[Regulation of lymphokine-activated killer (LAK) cells by cytokines].
Jiang CY, Tang PX. Jiang CY, et al. Sheng Li Ke Xue Jin Zhan. 1992 Apr;23(2):155-8. Sheng Li Ke Xue Jin Zhan. 1992. PMID: 1411439 Review. Chinese. No abstract available.
Sequential TNF and TGF-beta regulation of expansion and induction of cytotoxicity in long-term cultures of lymphokine-activated killer cells.
Koberda J, Przepiorka D, Moser RP, Grimm EE. Koberda J, et al. Lymphokine Cytokine Res. 1994 Apr;13(2):139-45. Lymphokine Cytokine Res. 1994. PMID: 8061115
[The effect of interleukin-2, interleukin-4 and tumor necrosis factor on LAK cells activity].
Zeng Z, Si CW, Yu M. Zeng Z, et al. Zhonghua Yi Xue Za Zhi. 1994 Apr;74(4):235-7, 256. Zhonghua Yi Xue Za Zhi. 1994. PMID: 7922766 Chinese.
Adoptive cellular immunotherapy for cancer: interleukin-2 activated lymphocytes.
Wolf JA Jr, Grimm EA. Wolf JA Jr, et al. Curr Opin Oncol. 1989 Dec;1(2):249-57. Curr Opin Oncol. 1989. PMID: 2489968 Review. No abstract available.

Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid: identification of transforming growth factor-beta as a suppressive factor.
Hirte H, Clark DA. Hirte H, et al. Cancer Immunol Immunother. 1991;32(5):296-302. doi: 10.1007/BF01789047. Cancer Immunol Immunother. 1991. PMID: 1998971 Free PMC article.
Interleukin-2-activated killer cell activity in colorectal tumor patients: evaluation of in vitro effects by prothymosin alpha1.
Eckert K, Grünberg E, Immenschuh P, Garbin F, Kreuser ED, Maurer HR. Eckert K, et al. J Cancer Res Clin Oncol. 1997;123(8):420-8. doi: 10.1007/BF01372545. J Cancer Res Clin Oncol. 1997. PMID: 9292704 Free PMC article.